“The Texas judge who could overturn the government’s approval of a key abortifacient drug scheduled the case’s first hearing for Wednesday, but took unusual steps to prevent it from going public,” said THE Washington Post reports.
“The hearing will be an opportunity for attorneys for the Justice Department, the company that makes the drug, and the conservative group challenging it to argue their positions before U.S. District Court Judge Matthew Kacsmaryk. After that, the judge could rule at any time.
